From 15 October to the compulsory Green pass in companies. Green certification will be necessary for all workers, and even for any collaborators and suppliers who may have access to the facilities.
The obligation will remain until 31 December, the end of the state of emergency, although the decree relating to the envisaged rules could undergo changes.
CHECKS - The indications provide for daily checks and preferably on access to the company, on a sample basis (not less than 20% and with a rotation criterion) or on a carpet, with or without the aid of automatic systems.
In general, those who do not have the green pass will not be able to work. The lack of the document will be considered an unjustified absence and therefore the payment of the salary will be suspended, but without disciplinary sanction. On the other hand, the obligation of green pass is not foreseen for those who will be able to show a medical certificate in which it is explained that the worker cannot be vaccinated. Certifications can be issued by vaccination services doctors and general practitioners.
The validity times of the green passport to those who perform the swabs do not change and remain 48 hours with rapid test and 72 with molecular. Therefore no "derogation" or modification of the rules at the last minute and therefore the non-vaccinated (exempt with certificate excluded) will have to adapt.
WHO CONTROLS - The control of the green pass is up to the employer: whoever omits the controls risks an administrative penalty ranging from 400 to 1,000 euros. The entrepreneur must appoint a control officer. Verification of the green pass can be carried out by scanning the QR code, using only the "VerificationC19" app. The verification activities cannot, in any case, involve the collection of the data of the holder.
THE KNOTS - Many difficulties could arise in construction sites or contractors, since those without a pass could block the progress of a certain chain of work. Just as the question of foreign workers - especially from the East - vaccinated with Sputnik, a serum not recognized by the EMA, remains open. On the latter aspect there are several hypotheses under study, one of these is to carry out an additional additional dose with an mRna vaccine in those who are vaccinated with sera not recognized by the EMA. Then there are those who think of installing turnstiles while others complain of the increase in costs that will be determined by the necessary controls.
